BUSINESS ANALYSIS
- GlaxosmithKline Pharmaceuticals Ltd was founded in the year 2000.
- The headquarters of GSK is in London, UK.
- They deal in the industry of Pharmaceutical, Biotechnology and Consumer goods.
- GSK offers wide products such as Pharmaceuticals, Vaccines, Oral healthcare, nutritional products and over the counter medicines.
- The number of employees associated with GSK are 99,000.
- Listing: NSE: GLAXO, BSE: 500660.
Let’s understand the financial aspect of GSK share price.
Table of Contents
FINANCIAL ANALYSIS
The market capitalization of the stock is Rs. 25,584 Cr.
The price to earnings ratio is 54.4 which is lesser than the industry price to earnings ratio of 62.6.
The company has an excellent return on capital employed of 43.8% which is a great sign of growth in the upcoming future and confirms that it will be a multibagger stock.
The return on equity is 28.3% which makes us double sure on the growth capability.
The company has ‘zero’ debt to equity ratio which tends to indicate that the company has paid all of its loans.
With increasing profits, the company is not forgetting its valuable investors and has been paying a healthy dividend of 315.02%.
GSK stands tall at 3rd position competing with the market leaders such as Abbott India and Pfizer based on its current market capitalization.
QUARTERLY RESULTS
(All values are in Rs. Cr)
Quarterly Results | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 |
Sales | 816 | 825 | 751 | 788 | 882 | 779 | 776 | 649 | 879 | 857 | 814 | 790 |
Expenses | 651 | 688 | 588 | 623 | 688 | 654 | 602 | 535 | 674 | 652 | 643 | 638 |
Operating Profit | 165 | 137 | 163 | 165 | 194 | 124 | 174 | 114 | 205 | 206 | 171 | 152 |
Other Income | 3 | 45 | 73 | 31 | 417 | -737 | 27 | 58 | -55 | 25 | -89 | 32 |
Profit before tax | 157 | 170 | 222 | 176 | 587 | -634 | 177 | 149 | 127 | 211 | 63 | 165 |
Tax % | 0.36 | 0.33 | 0.34 | 0.36 | 0.14 | -0.04 | 0.22 | 0.26 | 0.4 | 0.26 | 0.77 | 0.27 |
Net Profit | 101 | 114 | 147 | 114 | 503 | -661 | 138 | 111 | 76 | 157 | 14 | 121 |
EPS in Rs | 5.95 | 6.71 | 8.67 | 6.7 | 29.68 | -39.03 | 8.15 | 6.54 | 4.51 | 9.24 | 0.85 | 7.15 |
From the last 3 quarters the company has shown excellent results with an exponential rise in the sales.
In the last quarter of March 2021, the expenses of the company have reduced which indicates that the company is focusing on generating more profits.
There was a tremendous rise in the operating profit for March 2021 which has paved a path for a brighter future.
The earnings per share value is Rs 21.14 which is greater at such cheaper market price.
BALANCE SHEET
(All values are in Rs. Cr)
Balance Sheet | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
Share Capital | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 169 | 169 | 169 |
Reserves | 1701 | 1867 | 1851 | 1922 | 1905 | 1744 | 2099 | 1922 | 1973 | 1970 | 1651 | 1330 |
Borrowings | 5 | 5 | 5 | 5 | 4 | 3 | 2 | 2 | 1 | 1 | 0 | 0 |
This is a brief overview of the Financials of the company which showcases the strong footprint it has in Pharmaceutical Industry.
The balance sheet of this multibagger stock is pretty awesome with a borrowings of zero.
The share capital has doubled from 85 Cr to 169 Cr.
There is a decrease in the total liabilities year on year.
For the March 2021, the company had a net cash flow of Rs 300 Cr which the company will definitely use for expansion and growth as the debt associated with them is zero.
SHARE HOLDING PATTERN
Share Holding | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 |
Promoters | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
FIIs | 1.47 | 1.45 | 1.35 | 0.54 | 0.51 | 0.3 | 0.23 | 0.98 | 1.54 | 1.59 | 1.61 | 1.72 |
DIIs | 11.01 | 11.08 | 11.13 | 10.97 | 11.02 | 11.37 | 12.11 | 11.26 | 10.77 | 10.85 | 10.93 | 10.83 |
Public | 12.52 | 12.47 | 12.52 | 13.49 | 13.47 | 13.33 | 12.66 | 12.76 | 12.69 | 12.56 | 12.46 | 12.45 |
Promoters are very confident with the performance of the company and hence kept a holding of 75%.
This is the maximum percentage the promoters can hold in a company.
The FII’s have a 1.72% holding.
The DII’s have a 10.83% holding while only 12.45% is with the public.
GSK share price has some promising technical prospect so let’s check it.
TECHNICAL ANALYSIS (06th JULY 2021)
If we give a closer look on the chart of GSK share price in a daily timeframe, we would be able to see a formation of rounding bottom pattern on this multibagger stock.
This pattern fascinates us a lot as the success chances of the pattern is awesome.
The pattern is under formation and finding out such stocks in such a stage will definitely give good returns.
The current market price on 06th July 2021 is Rs. 1511.70 which would definitely vary in the upcoming future.
The below image shows the chart pattern which is under formation.

DISCLAIMER:
This analysis is only for study purpose. Please don’t buy or sell the stocks based on these analysis. Everyday prices vary so there will be a definite change in the chart patterns as well. We just intent to share the stock information through this platform.
Pingback: GSK INDIA SHARE PRICE: Target Achieved!!! - LearnTwoTrade